| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7fd15d8ebb22202b5cfe2b109cd922c5 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2014-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5db7b0b72a2f182541ab0bec36d62c55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33414d4b140a882e29a34227a6933b12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b49677a845243272aecf9a10c829533e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ada52f30e40ed58b54f9c1d73bb1348
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a716e5c250d7a6af0357f4b5c18aa0ca |
| publicationDate |
2015-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20150102597-A |
| titleOfInvention |
TET1, a marker for predicting the response to anti-cancer drug in a patient with ovarian cancer |
| abstract |
The present invention relates to a composition, a kit and a method for predicting an anticancer drug therapeutic response of an ovarian cancer patient by detecting a methylation level or a TET1 expression level of a CpG region of TET1 (Tet Methylcytosine Dioxygenase 1) gene. |
| priorityDate |
2014-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |